Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Palot (Marseille, France), S. Launois (Paris, France), X. Nguyen (Paris, France), A. Prigent (Rennes, France), D. Recart (Biarritz, France), C. Koltes (Metz, France), E. Aversenq (Saint-Priest, France), A. Graml (Munich, Germany), F. Lavergne (Saint-Priest, France). Prospective cohort study of patients complaining of high pressure with CPAP/APAP (PAP) who switch to bi-level PAP (VAuto) as second-line therapy: POP-IN study. 4150

Member's Comments

No comment yet.

Related content which might interest you: Negative pressure ventilation (NPV) by iron lung versus noninvasive positive pressure ventilation (NPPV) in the treatment of acute respiratory failure (ARF) in COPD patients: a prospective randomized multicentre study Source: Eur Respir J 2001; 18: Suppl. 33, 185s Year: 2001 Late Breaking Abstract - Continuous positive airway pressure (CPAP) as an intervention for acute hypoxia in not-for-escalation (NFE) COVID-19 pneumonia patients: a single-centre observational study with retrospective cohort analysis Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Effect of continuous positive airway pressure (CPAP) on resistant hypertension. A randomised, controlled study Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Buteyko technique (BT) as an adjunct in pulmonary rehabilitation (PR) in patients with asthma and dysfunctional breathing – First results of an ongoing prospective controlled study Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation Year: 2012 LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Noninvasive positive pressure ventilation (NPPV) in the treatment of acute respiratory failure in patients with morbid obesity: a prospective cohort study Source: Eur Respir J 2004; 24: Suppl. 48, 313s Year: 2004 Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Negative pressure ventilation (NPV) by iron lung versus conventional mechanical ventilation (CMV) in the treatment of acute respiratory failure (ARF) in COPD patients: a prospective randomized controlled study Source: Eur Respir J 2001; 18: Suppl. 33, 185s Year: 2001 LATE-BREAKING ABSTRACT: Effect of CPAP treatment on blood pressure levels in resistant hypertension. A multicenter randomized study from the Spanish sleep network (NCT00616265) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 A multicenter randomised controlled trial to evaluate continuous-positive airway pressure (CPAP) versus conventional oxygen in patients with acute respiratory failure (ARF) due to community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure Year: 2009 A new UK approach in the management of patients on continuous positive airway pressure (CPAP) therapy Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003 Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study) Source: Annual Congress 2008 - Management of COPD Year: 2008 PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH) Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 A prospective observational study on long-term non invasive ventilation (L-T NIV) in COPD patients attending an inpatient pulmonary rehabilitation program (PRP) Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 The effect of early use of continuous positive airway pressure (CPAP) therapy to treat acute atelectasis after cardiac surgery: Randomized study Source: Annual Congress 2011 - Sleep and weight: heavy under pressure Year: 2011 A prospective study for improvement of acute asthma by non-invasive positive pressure ventilation (NPPV) Source: Eur Respir J 2006; 28: Suppl. 50, 188s Year: 2006